However, as suggested by Tosca et al., in the near future, NGS targeted to AMH and AMHR2 may become the method of choice for diagnosing PMDS, with the capacity for detecting both SNVs and CNVs in a single step [8]. The gene discussed is AMHR2; the disease is persistent Mullerian duct syndrome.